Announced Wed, 22 Jul · 15:30 IST
Board meeting on 25 July 2026 to consider Q1 FY2027 results
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+4.0%1-day move
₹49.02
prior close
₹50.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+4.0+7.6————————
Up moveDown movePending
AI summary
Oxygenta Pharmaceutical has informed BSE that its Board of Directors will meet on Saturday, 25 July 2026 to consider and approve the unaudited financial results and limited review report for the quarter ended 30 June 2026. This is a standard quarterly results intimation under SEBI listing rules.
Likely market impact
Routine quarterly results announcement. Watch for actual numbers on 25 July 2026 as they may move the stock.